Ann R. Falsey
Professor (Part-Time) - Department of Medicine, Infectious Diseases · University Of Rochester School Of Medicine
Credentials: · · · ·
History
- Present
University Of Rochester School Of Medicine
- 1987–1988
Yale New Haven Hospital Temple Medical Center
Research
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
New England Journal of Medicine · 2020 · 2,023 citations
Respiratory syncytial virus infection in elderly and high-risk adults
New England Journal of Medicine · 2005 · First of 5 authors · Corresponding · 1,766 citations
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults
Nature · 2020 · 1,134 citations
133 papers
44 papers · 3 as a fellow
20 papers
19 papers
18 papers
17 papers
- NR
17 papers
14 papers
Grants
- 2019–2026
University of Rochester Vaccine and Treatment Evaluation Unit (VTEU)
National Institute of Allergy and Infectious Diseases · UM1
Contact PI · $20.6M · University of Rochester
- 2019–2026
Transcriptional Profiling to Discriminate Bacterial and Non-Bacterial Respiratory Illnesses
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $3.8M · University of Rochester
- 2008–2013
Reduction of Uneccessary Antibiotics in Adults by the Use of Viral Diagnostics
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $1.8M · University of Rochester
- 2005–2009
Human Metapneumovirus Infection in Adults
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $659.7K · University of Rochester
Clinical trials
- 2023–2024
Immunogenicity of RSV Vaccines in Residents of Long-Term Care Facilities (LTCF)
Principal investigator · Completed · Phase 4
University of Rochester
- 2020–2023
Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults
Principal investigator · Completed · Phase 3
AstraZeneca
- 2013–2014
Viral Testing and Biomarkers to Reduce Antibiotic Use for Respiratory Infections
Principal investigator · Completed
University of Rochester